1. Home
  2. ADAG vs HNNA Comparison

ADAG vs HNNA Comparison

Compare ADAG & HNNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAG
  • HNNA
  • Stock Information
  • Founded
  • ADAG 2011
  • HNNA 1989
  • Country
  • ADAG China
  • HNNA United States
  • Employees
  • ADAG N/A
  • HNNA N/A
  • Industry
  • ADAG Biotechnology: Pharmaceutical Preparations
  • HNNA Investment Managers
  • Sector
  • ADAG Health Care
  • HNNA Finance
  • Exchange
  • ADAG Nasdaq
  • HNNA Nasdaq
  • Market Cap
  • ADAG 81.9M
  • HNNA 82.4M
  • IPO Year
  • ADAG 2021
  • HNNA N/A
  • Fundamental
  • Price
  • ADAG $1.42
  • HNNA $10.99
  • Analyst Decision
  • ADAG Strong Buy
  • HNNA
  • Analyst Count
  • ADAG 1
  • HNNA 0
  • Target Price
  • ADAG $8.00
  • HNNA N/A
  • AVG Volume (30 Days)
  • ADAG 29.9K
  • HNNA 23.5K
  • Earning Date
  • ADAG 03-24-2025
  • HNNA 05-07-2025
  • Dividend Yield
  • ADAG N/A
  • HNNA 5.00%
  • EPS Growth
  • ADAG N/A
  • HNNA 75.66
  • EPS
  • ADAG N/A
  • HNNA 1.12
  • Revenue
  • ADAG $103,204.00
  • HNNA $33,210,000.00
  • Revenue This Year
  • ADAG $6,488.89
  • HNNA N/A
  • Revenue Next Year
  • ADAG $57.50
  • HNNA N/A
  • P/E Ratio
  • ADAG N/A
  • HNNA $9.24
  • Revenue Growth
  • ADAG N/A
  • HNNA 38.27
  • 52 Week Low
  • ADAG $1.33
  • HNNA $6.60
  • 52 Week High
  • ADAG $3.58
  • HNNA $13.88
  • Technical
  • Relative Strength Index (RSI)
  • ADAG 39.32
  • HNNA 60.98
  • Support Level
  • ADAG $1.36
  • HNNA $9.46
  • Resistance Level
  • ADAG $1.92
  • HNNA $10.78
  • Average True Range (ATR)
  • ADAG 0.13
  • HNNA 0.73
  • MACD
  • ADAG -0.00
  • HNNA 0.19
  • Stochastic Oscillator
  • ADAG 13.79
  • HNNA 99.61

About ADAG Adagene Inc.

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.

About HNNA Hennessy Advisors Inc.

Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced, and fixed income products. It also provides investment advisory services and shareholder services to the Hennessy Funds which include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities as per the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.

Share on Social Networks: